PortfoliosLab logoPortfoliosLab logo
CANC vs. XHS
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

CANC vs. XHS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Oncology ETF (CANC) and SPDR S&P Health Care Services ETF (XHS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CANC vs. XHS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CANC
Tema Oncology ETF
5.69%42.92%-5.37%510.51%-85.34%-51.82%
XHS
SPDR S&P Health Care Services ETF
-6.26%18.83%1.76%5.15%-19.87%1.84%

Returns By Period

In the year-to-date period, CANC achieves a 5.69% return, which is significantly higher than XHS's -6.26% return.


CANC

1D
4.66%
1M
-2.88%
YTD
5.69%
6M
27.93%
1Y
52.46%
3Y*
140.00%
5Y*
10Y*

XHS

1D
1.87%
1M
-7.51%
YTD
-6.26%
6M
-1.26%
1Y
2.34%
3Y*
5.33%
5Y*
-1.07%
10Y*
6.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CANC vs. XHS - Expense Ratio Comparison

CANC has a 0.75% expense ratio, which is higher than XHS's 0.35% expense ratio.


Return for Risk

CANC vs. XHS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CANC
CANC Risk / Return Rank: 9090
Overall Rank
CANC Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CANC Sortino Ratio Rank: 9090
Sortino Ratio Rank
CANC Omega Ratio Rank: 8282
Omega Ratio Rank
CANC Calmar Ratio Rank: 9494
Calmar Ratio Rank
CANC Martin Ratio Rank: 9393
Martin Ratio Rank

XHS
XHS Risk / Return Rank: 1616
Overall Rank
XHS Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
XHS Sortino Ratio Rank: 1515
Sortino Ratio Rank
XHS Omega Ratio Rank: 1515
Omega Ratio Rank
XHS Calmar Ratio Rank: 1717
Calmar Ratio Rank
XHS Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CANC vs. XHS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Oncology ETF (CANC) and SPDR S&P Health Care Services ETF (XHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CANCXHSDifference

Sharpe ratio

Return per unit of total volatility

1.94

0.12

+1.82

Sortino ratio

Return per unit of downside risk

2.59

0.30

+2.29

Omega ratio

Gain probability vs. loss probability

1.32

1.04

+0.29

Calmar ratio

Return relative to maximum drawdown

3.86

0.25

+3.61

Martin ratio

Return relative to average drawdown

13.76

0.68

+13.08

CANC vs. XHS - Sharpe Ratio Comparison

The current CANC Sharpe Ratio is 1.94, which is higher than the XHS Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of CANC and XHS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


CANCXHSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.94

0.12

+1.82

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.05

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.04

0.52

-0.56

Correlation

The correlation between CANC and XHS is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

CANC vs. XHS - Dividend Comparison

CANC's dividend yield for the trailing twelve months is around 0.05%, less than XHS's 0.29% yield.


TTM20252024202320222021202020192018201720162015
CANC
Tema Oncology ETF
0.05%0.06%3.00%0.56%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XHS
SPDR S&P Health Care Services ETF
0.29%0.27%0.38%0.23%0.19%0.20%0.23%2.37%0.34%0.22%0.28%0.93%

Drawdowns

CANC vs. XHS - Drawdown Comparison

The maximum CANC drawdown since its inception was -97.53%, which is greater than XHS's maximum drawdown of -39.32%. Use the drawdown chart below to compare losses from any high point for CANC and XHS.


Loading graphics...

Drawdown Indicators


CANCXHSDifference

Max Drawdown

Largest peak-to-trough decline

-97.53%

-39.32%

-58.21%

Max Drawdown (1Y)

Largest decline over 1 year

-12.40%

-12.61%

+0.21%

Max Drawdown (5Y)

Largest decline over 5 years

-32.62%

Max Drawdown (10Y)

Largest decline over 10 years

-39.32%

Current Drawdown

Current decline from peak

-56.19%

-12.33%

-43.86%

Average Drawdown

Average peak-to-trough decline

-73.91%

-10.27%

-63.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.61%

4.53%

-0.92%

Volatility

CANC vs. XHS - Volatility Comparison

Tema Oncology ETF (CANC) has a higher volatility of 8.36% compared to SPDR S&P Health Care Services ETF (XHS) at 4.98%. This indicates that CANC's price experiences larger fluctuations and is considered to be riskier than XHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CANCXHSDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.36%

4.98%

+3.38%

Volatility (6M)

Calculated over the trailing 6-month period

16.34%

12.45%

+3.89%

Volatility (1Y)

Calculated over the trailing 1-year period

27.24%

19.25%

+7.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

285.66%

21.05%

+264.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

285.66%

22.41%

+263.25%